Related Experiment Video
Updated: Jul 8, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
[Malignant pleural mesothelioma: interrogations and hopes concerning the expected epidemic]
1Service de Pneumologie, Hôpital d'Instruction des Armées Percy, 101, avenue Henri-Barbusse, 92140 Clamart. j.margery@free.fr
Abstract:
Malignant pleural mesothelioma (MPM) is a rare incurable tumor. Interest in MPM has increased in recent years due to a steadily increasing incidence subsequent to the intensive use of asbestosis, the main causal agent, but also due to better awareness in the political and scientific communities faced with a serious public health issue. Our knowledge of MPM has improved regularly in terms of pathologic diagnosis and the mechanisms underlying the mesothelial carcinogenesis. MPM is also the subject of many technological innovations as illustrated by the recent identification of new biological markers, access to metabolic imaging, and clinical research on targeted treatments. Proper management implies the participation of the general population since the implementation of administrative procedures for social indemnities. In 2007, a more aggressive therapeutic approach is becoming common practice with the use of radiotherapy and the emergence of the concept of multimodal care centered on wide pleuropneumonectomy. These advances create real hope for improvement, but also many interrogations since no standard treatment protocol has been clearly identified.
Insights
Malignant pleural mesothelioma (MPM) is a rare, incurable cancer linked to asbestos exposure. Advances in diagnosis and multimodal treatments offer hope, but a standard protocol remains elusive.
Area of Science:
- Oncology
- Public Health
- Pathology
Context:
- Malignant pleural mesothelioma (MPM) incidence is rising due to historical asbestos use.
- Increased awareness highlights MPM as a significant public health concern.
- Recent technological innovations are improving MPM understanding and management.
Purpose:
- To review current knowledge and recent advancements in malignant pleural mesothelioma.
- To discuss diagnostic improvements, carcinogenesis mechanisms, and emerging biomarkers.
- To explore innovative therapeutic strategies and the need for standardized care.
Summary:
- MPM is a rare, incurable tumor with increasing incidence.
- Pathologic diagnosis and understanding of mesothelial carcinogenesis have improved.
- New biological markers, metabolic imaging, and targeted treatments are under investigation.
- Multimodal care, including radiotherapy and pleuropneumonectomy, is becoming standard.
- Despite progress, a definitive treatment protocol for MPM is still needed.
Impact:
- Improved diagnostic accuracy and understanding of MPM development.
- Identification of novel biomarkers and advanced imaging techniques for MPM.
- Development of more aggressive, multimodal treatment approaches for MPM patients.
- Highlights the need for standardized MPM treatment protocols to optimize patient outcomes.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax-II
Clinical Manifestations:
Pleura of the Lungs
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due to...
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...

